Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001437:Bacteriuria; D003428:Cross Infection / Q000209:etiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009305:Nasopharynx / Q000382:microbiology; D011014:Pneumonia / Q000382:microbiology; D011175:Positive-Pressure Respiration / Q000009:adverse effects; D012138:Respiratory Therapy / Q000009:adverse effects*; D018805:Sepsis / Q000382:microbiology; D012706:Serratia marcescens / Q000302:isolation & purification; D013183:Sputum / Q000382:microbiology; D013530:Surgical Wound Infection / Q000382:microbiology
D000900:Anti-Bacterial Agents